Isolation, characterization and neuroprotective activity of folecitin: An in vivo study

Abstract

Neurodegenerative diseases (NDs) extend the global health burden. Consumption of alcohol as well as maternal exposure to ethanol can damage several neuronal functions and cause cognition and behavioral abnormalities. Ethanol induces oxidative stress that is linked to the development of NDs. Treatment options for NDs are yet scarce, and natural product‐based treatments could facilitate ND management since plants possess plenty of bioactive metabolites, including flavonoids, which typically demonstrate antioxidant and anti‐inflammatory properties. Hypericum oblongifolium is an important traditional medicinal plant used for hepatitis, gastric ulcer, external wounds, and other gastrointestinal disorders. However, it also possesses multiple bioactive compounds and antioxidant properties, but the evaluation of isolated pure compounds for neuroprotective efficacy has not been done yet. Therefore, in the current study, we aim to isolate and characterize the bioactive flavonoid folecitin and evaluate its neuroprotective activity against ethanol‐induced oxidative‐stress‐mediated neurodegeneration in the hippocampus of postnatal day 7 (PND‐7) rat pups. A single dose of ethanol (5 g/kg body weight) was intraperitoneally administered after the birth of rat pups on PND‐7. This caused oxidative stress accompanied by the activation of phosphorylated‐c‐Jun N‐terminal kinase (p‐JNK), nod‐like receptor family pyrin domain containing 3 (NLRP3), apoptosis‐associated speck‐like protein (ASC), and cysteine‐aspar-tic acid protease‐1 (caspase‐1) proteins to form a complex called the NLRP3‐inflammasome, which converts pro‐interleukin 1 beta (IL‐1B) to activate IL‐1B and induce widespread neuroinflammation and neurodegeneration. In contrast, co‐administration of folecitin (30 mg/kg body weight) reduced ethanol‐in-duced oxidative stress, inhibited p‐JNK, and deactivated the NLRP3‐inflammasome complex. Furthermore, folecitin administration reduced neuroinflammatory and neurodegenerative protein markers, including decreased caspase‐3, BCL‐2‐associated X protein (BAX), B cell CLL/lymphoma 2 (BCL‐2), and poly (ADP‐ribose) polymerase‐1 (PARP‐1) expression in the immature rat brain. These findings conclude that folecitin is a flavone compound, and it might be a novel, natural and safe agent to curb oxidative stress and its downstream harmful effects, including inflammasome activation, neuroinflammation, and neurodegeneration. Further evaluation in a dose‐dependent manner would be worth it in order to find a suitable dose regimen for NDs.